Thursday, May 02, 2019 11:13:54 AM
EMAIL FROM IR:
Thank you for your interest in Charlotte’s Web. Yes, you are correct, as part of its multi-channel evaluation for expanded distribution and reach, Charlotte’s Web is exploring a direct seller program with supplement manufacturer Plexus. This is for a Plexus-branded product containing Charlotte’s Web hemp-extract. This is different than the Charlotte’s Web branded products you will find on our online store or at a retailer. Specifically, Plexus will be piloting an exclusive 30ml bottle of Blueberry Lavender flavored hemp extract oil containing 17mg/ml plant-based cannabinoids. This exclusive flavor has the Plexus customer in mind, and we are keen to see what kind of traction ensues. The innovative pilot program provides access to a customer demographic that would otherwise not be exposed to our digital or traditional advertising media. More importantly, the structure of the Plexus direct-selling organization offers consumer education moments not easily available through traditional retail channels. Direct consumer-to-consumer selling harnesses the power of word-of-mouth exposure – by far the most effective tool in an industry that is limited in its formal advertising – by contracting affiliates or brand ambassadors to communicate consumer-to-consumer. We believe the uniquely high consumer touch model through Plexus enables consistent exposure and education surrounding the health benefits from full-spectrum extracts and cannabinoids, an ongoing effort Charlotte’s Web has been at the forefront of since its inception. Because of this, direct C2C has already come to represent a large part of the overall CBD industry. Direct selling is big business and a meaningful distribution channel for CBD products. The Plexus organization has more than 700,000 members / product ambassadors generating more than $500M in annual sales. All members will be issued detailed documentation and mandatory training on the exclusive hemp extract and the overall CBD wellness category. This strategy reaches a vast pool of consumers by leveraging the benefits of word-of mouth marketing and at superior margins compared to the mass retail channel. This exploratory collaboration brings a quality CBD product into the C2C channel as Charlotte’s Web remains as committed as ever to its high standards and consistency for which it is known and trusted.
Thank you for your interest in Charlotte’s Web. Yes, you are correct, as part of its multi-channel evaluation for expanded distribution and reach, Charlotte’s Web is exploring a direct seller program with supplement manufacturer Plexus. This is for a Plexus-branded product containing Charlotte’s Web hemp-extract. This is different than the Charlotte’s Web branded products you will find on our online store or at a retailer. Specifically, Plexus will be piloting an exclusive 30ml bottle of Blueberry Lavender flavored hemp extract oil containing 17mg/ml plant-based cannabinoids. This exclusive flavor has the Plexus customer in mind, and we are keen to see what kind of traction ensues. The innovative pilot program provides access to a customer demographic that would otherwise not be exposed to our digital or traditional advertising media. More importantly, the structure of the Plexus direct-selling organization offers consumer education moments not easily available through traditional retail channels. Direct consumer-to-consumer selling harnesses the power of word-of-mouth exposure – by far the most effective tool in an industry that is limited in its formal advertising – by contracting affiliates or brand ambassadors to communicate consumer-to-consumer. We believe the uniquely high consumer touch model through Plexus enables consistent exposure and education surrounding the health benefits from full-spectrum extracts and cannabinoids, an ongoing effort Charlotte’s Web has been at the forefront of since its inception. Because of this, direct C2C has already come to represent a large part of the overall CBD industry. Direct selling is big business and a meaningful distribution channel for CBD products. The Plexus organization has more than 700,000 members / product ambassadors generating more than $500M in annual sales. All members will be issued detailed documentation and mandatory training on the exclusive hemp extract and the overall CBD wellness category. This strategy reaches a vast pool of consumers by leveraging the benefits of word-of mouth marketing and at superior margins compared to the mass retail channel. This exploratory collaboration brings a quality CBD product into the C2C channel as Charlotte’s Web remains as committed as ever to its high standards and consistency for which it is known and trusted.
Recent CWBHF News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:08:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:07:49 AM
- Charlotte's Web First Quarter 2026 Financial Results • Newsfile • 05/13/2026 11:07:00 AM
- OTC Markets Group Welcomes Charlotte's Web Holdings Inc. to OTCQX • GlobeNewswire Inc. • 04/30/2026 11:00:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/16/2026 07:03:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 07:03:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 07:02:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 04:30:15 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/06/2026 09:07:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:29:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 11:18:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 09:30:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/01/2026 09:29:45 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 11:08:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:07:30 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 11:07:11 AM
- Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results • PR Newswire (US) • 03/31/2026 11:07:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 10:46:21 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 10:45:01 AM
- Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet • PR Newswire (US) • 03/31/2026 02:59:00 AM
- Charlotte's Web 2025 Fourth Quarter and Year-End Earnings Call and Webcast Notice • PR Newswire (US) • 03/24/2026 01:15:00 PM
- Charlotte's Web Welcomes New CMS Guidance, Advancing Access to Eligible Full‑Spectrum Hemp Products • PR Newswire (US) • 03/21/2026 01:53:00 AM
